Results of a multicenter, randomized, double‐blind phase 2/3 study of lenalidomide in the treatment of pretreated relapsed or refractory metastatic malignant melanoma von Eisen, Tim, Trefzer, Uwe, Hamilton, Anne, Hersey, Peter, Millward, Michael, Knight, Robert D., Jungnelius, Jarl U., Glaspy, John

Volltext

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma von Rini, B., Redman, B., Garcia, J.A., Burris, H.A., Li, S., Fandi, A., Beck, R., Jungnelius, U., Infante, J.R.

Volltext

Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trial von Jungnelius, U, Ringborg, U, Aamdal, S, Mattsson, J, Stierner, U, Ingvar, C, Malmström, P, Andersson, R, Karlsson, M, Willman, K, Wist, E, Bjelkengren, G, Westberg, R

Volltext

613PPhase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer von Halama, N, Prüfer, U, Froemming, A, Beyer, D, Eulberg, D, Jungnelius, J U, Mangasarian, A

Volltext

A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone (DP) with or without Lenalidomide (LEN) in Patients with Castrate-Resistant Prostate Cancer (CRPC):... von Petrylak, D.P., Fizazi, K., Sternberg, C.N., Budnik, N., De Wit, R., Wiechno, P.J., Bellmunt, J., Barton, D., Fandi, A., Jungnelius, U., Li, S., Vogelzang, N.

Volltext

A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma von Rini, B, Redman, B, Garcia, J A, Burris, 3rd, H A, Li, S, Fandi, A, Beck, R, Jungnelius, U, Infante, J R

Volltext

High-Dose cisplatin treatment: Hearing loss and plasma concentrations von Laurell, Göran, Jungnelius, Ulf

Volltext

Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid von HANSSON, J, BERHANE, K, CASTRO, V. M, JUNGNELIUS, U, MANNERVIK, B, RINGBORG, U

Volltext

Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma : a phase I-II trial von RINGBORG, U, JUNGNELIUS, U, HANSSON, J, STRANDER, H

Volltext

A phase I study of weekly gemcitabine as a radiosensitiser in stage III non-small cell lung cancer von Price, A, Groen, H, Gregor, A, van Putten, J, van der Leest, A, Little, F, Wets, M, Jungnelius, U

Volltext

Correlation of DNA ploidy and S‐phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma von Karlsson, Margareta, Jungnelius, Ulf, Aamdal, Steinar, Boeryd, Bernt, Carstensen, John, Kågedal, Bertil, Westberg, Ronny, Wingren, Sten

Volltext

17 Drug resistance factors in malignant melanoma: possible implications for adjuvant therapy von Hansson, J., Egyházi, S., Jungnelius, U., Ringborg, U.

Volltext

Similar toxic effect of 1,3-BIS(2-chloroethyl)-1-nitrosourea on lymphocytes from human subjects differing in the expression of glutathione transferase M1-1 von Jungnelius, Ulf, Rldderström, Marianne, Hansson, Johan, Ringborg, Ulrik, Mannervik, Bengt

Volltext

A low expression of glutathione transferase (GST) alpha in melanoma metastases is correlated to response to dacarbazine containing chemotherapy: 416 von Jungnelius, U, Grafstr??m, E, Platz, A, Mannervik, B, Ringborg, U

Volltext

4 Cutaneous malignant melanoma: prognostic factors of distant metastases von Ringborg, U., Jungnelius, U., Mansson-Brahme, E., Cedermark-Cohn, G., Hansson, J.

Volltext

Glutathione Transferase P1-1 Expression in Human Melanoma Metastases: Correlation to N-RAS mutations and expression von Platz, Anton, Jungnelius, Ulf, Grafström, Eva, Lagerlöf, Bengt, Mannervik, Bengt, Ringborg, Ulrik

Volltext

Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial von Ringborg, U, Jungnelius, U, Hansson, J, Strander, H

Volltext

Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferases von JUNGNELIUS, U, XIAO-YONG HAO, SKOG, S, CASTRO, V. M, MANNERVIK, B, RINGBORG, U

Volltext

215 Dacarbazine-vindesine vs dacarbazine-vindesine-cisplatinum in disseminated melanoma—a randomized phase III trial von Jungnelius, U., Ringborg, U., Aamdahl, S., Rudenstam, C.-M., Stierner, U., Ingvar, C., Malmström, P., Andersson, R., Karlsson, M., Willman, K., Wist, E., Westberg, R.

Volltext

613P - Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer von Halama, N., Prüfer, U., Froemming, A., Beyer, D., Eulberg, D., Jungnelius, J.U., Mangasarian, A.

Volltext